Invenomic Capital Management’s Flex FLEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-376,331
Closed -$7.84M 155
2023
Q2
$7.84M Sell
376,331
-219,931
-37% -$3.92M 0.4% 69
2023
Q1
$10.3M Sell
596,262
-1,226,440
-67% -$21.2M 0.58% 55
2022
Q4
$29.5M Sell
1,822,702
-411,175
-18% -$6.17M 2% 10
2022
Q3
$28M Buy
2,233,877
+190,162
+9% +$2.43M 2.41% 6
2022
Q2
$22.3M Buy
2,043,715
+1,398,975
+217% +$17.3M 1.58% 12
2022
Q1
$6.22M Buy
644,740
+312,025
+94% +$3.99M 0.66% 46
2021
Q4
$4.6M Buy
+332,715
New +$4.5M 0.98% 37
2020
Q4
Sell
-118,179
Closed -$992K 154
2020
Q3
$992K Sell
118,179
-12,590
-10% -$103K 0.55% 57
2020
Q2
$1.01M Sell
130,769
-7,567
-5% -$54.5K 0.75% 48
2020
Q1
$873K Sell
138,336
-285,954
-67% -$2.47M 0.71% 53
2019
Q4
$4.04M Buy
+424,290
New +$3.66M 1.62% 17

Other funds holding FLEX

Invenomic Capital Management's FLEX Position: Q3 2023 in Review

Invenomic Capital Management sold out of Flex (FLEX) in Q3 2023, closing a stake of 376,331 shares — an estimated $7.84M sold.

Invenomic Capital Management first reported a position in FLEX in Q4 2019 and held it in 11 quarters. The position peaked at $29.5M in Q4 2022. 448 funds tracked by Wall St. Rank hold FLEX as of Q3 2023.

  • Invenomic Capital Management reported no remaining Flex position as of Q3 2023 after selling out during the quarter.
  • Invenomic Capital Management sold 376,331 Flex shares in Q3 2023, an estimated $7.84M.
  • Invenomic Capital Management first reported a position in Flex in Q4 2019 and held it in 11 quarters.
  • Invenomic Capital Management's Flex position peaked at $29.5M in Q4 2022.
  • 448 funds tracked by Wall St. Rank held Flex as of Q3 2023.

Based on Invenomic Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.